Risk factors for mortality in post-myocardial infarction patients: insights from the improve SCA bridge study

Dileep Kumar1,2, Fawaz Bardooli3, Wen-Jone Chen4

  • 1Mohammed Bin Khalifa Specialist Cardiac Centre, Awali, Bahrain. dileep_dewani2011@yahoo.com.

Insights

Sudden cardiac death (SCD) risk factors in post-myocardial infarction (MI) patients include older age, reduced ejection fraction, and being from Southeast Asia. Identifying these patients can guide implantable cardioverter-defibrillator (ICD) use for prevention.

Area of Science:

  • Cardiology
  • Public Health

Background:

  • Implantable cardioverter-defibrillators (ICDs) are underutilized for preventing sudden cardiac death (SCD) in post-myocardial infarction (MI) patients.
  • Understanding regional risk factors is crucial for optimizing ICD adoption and patient selection.

Purpose of the Study:

  • To identify risk factors for all-cause and cardiovascular mortality in post-MI patients.
  • To inform strategies for SCD prevention in populations with low ICD use.

Main Methods:

  • Analysis of risk factors for mortality in post-MI patients from the Improve Sudden Cardiac Arrest (SCA) Bridge Trial.
  • Multivariate modeling to assess predictors of all-cause and cardiovascular mortality.

Main Results:

  • Overall 1-year mortality was 5.9% (all-cause) and 3.4% (cardiovascular), with 76.5% of cardiac deaths due to SCD.
  • Significant risk factors for all-cause mortality included increased age, reduced left ventricular ejection fraction (LVEF), longer time from MI to admission, female sex, being from Southeast Asia (SEA), and coronary artery disease.
  • Increased age, reduced LVEF, and being from SEA were significant risk factors for cardiovascular mortality.

Conclusions:

  • Specific patient characteristics predict cardiovascular mortality post-MI.
  • Patients with identified risk factors warrant electrophysiologist referral for SCD risk stratification.
  • Timely intervention, including potential ICD implantation, can reduce preventable deaths.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
137
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
1.3K
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
1.4K